Skip to main content

Advertisement

SpringerLink
Log in

Hypertension in Athletes and Active Populations

  • Antihypertensive Agents: Mechanisms of Drug Action (M Ernst, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Hypertension continues to be the most common cardiovascular disorder in the USA and worldwide. While generally considered a disorder of aging individuals, hypertension is more prevalent in athletes and the active population than is generally appreciated. The timely detection, diagnosis, and appropriate treatment of hypertension in athletes must focus on both adequately managing the disorder and ensuring safe participation in sport while not compromising exercise capacity. This publication focuses on appropriately diagnosing hypertension, treating hypertension in the athletic population, and suggesting follow-up and participation guidelines for athletes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322.

    Article  PubMed  Google Scholar 

  2. World Health Organization. Global status report on noncommunicable diseases 2010. Geneva: World Health Organization; 2011.

    Google Scholar 

  3. De Matos LD, Caldeira Nde A, Perlingeiro Pde S, et al. Cardiovascular risk and clinical factors in athletes: 10 years of evaluation. Med Sci Sports Exerc. 2011;43(6):943–50.

    Article  CAS  PubMed  Google Scholar 

  4. Kaplan NM, Gidding SS, Pickering TG, et al. Task force 5: systemic hypertension. J Am Coll Cardiol. 2005;45:1346–58.

    Article  PubMed  Google Scholar 

  5. Black HR, Sica D, Ferdinand K, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 6: hypertension: a scientific statement from the American Heart Association and the American College of Cardiology. Circulation. 2015;132(22):e298–302. Quick position statement by the AHA/ACC for participation recommendations for athletes with hypertension.

    Article  PubMed  Google Scholar 

  6. Karpinos AR, Roumie CL, Nian H, et al. High prevalence of hypertension among collegiate football athletes. Circ Cardiovasc Qual Outcomes. 2013;6(6):716–23. Sheds light into the prevalence of hypertension among collegiate football players.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Allen TW, Vogel RA, Lincoln AE, et al. Body size, body composition, and cardiovascular disease risk factors in NFL players. Phys Sportsmed. 2010;38(1):21–7.

    Article  PubMed  Google Scholar 

  8. Berge HM, Gierdalen GF, Andersen TE, et al. Blood pressure in professional male football players in Norway. J Hypertens. 2013;31(4):672–9. Describes a prevalence of hypertension among professional athletes in a sport outside of ASF.

    Article  CAS  PubMed  Google Scholar 

  9. Kouidi E, Fahadidou-Tsiligiroglou A, Tassoulas E, et al. White coat hypertension detected during screening of male adolescent athletes. Am J Hypertens. 1999;12(2 Pt 1):223–6.

    Article  CAS  PubMed  Google Scholar 

  10. Baron S, Rinsky R. National Institute for Occupational Safety and Health. NFL mortality study. Available at: http://www.cdc.gov/niosh/pdfs/nflfactsheet.pdf. Accessed July 25, 2016.

  11. Leddy JJ, Izzo J. Hypertension in athletes. J Clin Hypertens. 2009;11(4):226–33.

    Article  Google Scholar 

  12. Asplund C. Treatment of hypertension in athletes: an evidence-based review. Phys Sportsmed. 2010;38(1):37–44.

    Article  PubMed  Google Scholar 

  13. Handler J. The importance of accurate blood pressure measurement. Perm J. 2009;13(3):51–4.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.

    Article  CAS  PubMed  Google Scholar 

  15. McCambridge TM, Benjamin HJ, Brenner JS, et al. Athletic participation by children and adolescents who have systemic hypertension. Pediatrics. 2010;125(6):1287–94.

    Article  PubMed  Google Scholar 

  16. Pickering Pickering TG, Miller NH, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:1.

    Article  CAS  PubMed  Google Scholar 

  17. Andersen MJ, Khawandi W, Agarwal R. Home blood pressure monitoring in CKD. Am J Kidney Dis. 2005;45:994.

    Article  PubMed  Google Scholar 

  18. Parati G, Pickering TG. Home blood-pressure monitoring: US and European consensus. Lancet. 2009;373:876.

    Article  PubMed  Google Scholar 

  19. Stergiou GS, Skeva II, Baibas NM, et al. Diagnosis of hypertension using home or ambulatory blood pressure monitoring: comparison with the conventional strategy based on repeated clinic blood pressure measurements. J Hypertens. 2000;18:1745.

    Article  CAS  PubMed  Google Scholar 

  20. Niiranen TJ, Johansson JK, Reunanen A, Jula AM. Optimal schedule for home blood pressure measurement based on prognostic data: the Finn-Home Study. Hypertension. 2011;57:1081.

    Article  CAS  PubMed  Google Scholar 

  21. Parati G, Stergiou GS, Asmar R, et al. European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens. 2010;24:779.

    Article  CAS  PubMed  Google Scholar 

  22. Stiefel EC, Field L, Replogle W, et al. The prevalence of obesity and elevated blood pressure in adolescent student athletes from the state of Mississippi. Orthop J Sports Med. 2016 Feb 19;4(2). Great publication linking obesity with hypertension even in young athletes.

  23. Jago R, Harrell JS, McMurray RG, et al. Prevalence of abnormal lipid and blood pressure values among an ethnically diverse population of eighth-grade adolescents and screening implications. Pediatrics. 2006;117(6):2065–73.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Tucker AM, Vogel RA, Lincoln AE, et al. Prevalence of cardiovascular disease risk factors among National Football League players. JAMA. 2009;301(20):2111–9.

    Article  CAS  PubMed  Google Scholar 

  25. Feairheller DL, Aichele KR, Oakman JE, et al. Vascular health in American football players: cardiovascular risk increased in division III players. Int J Vasc Med. 2016; Epub 2016 Jan 24. Highlights the potentially elevated cardiovascular risk in ASF players.

  26. Rice TB, Dunn RE, Lincoln AE, et al. Sleep-disordered breathing in the National Football League. Sleep. 2010;33(6):819–24.

    PubMed  PubMed Central  Google Scholar 

  27. Berge HM, Isern CB, Berge E. Blood pressure and hypertension in athletes: a systematic review. Br J Sports Med. 2015;49(11):716–23. An excellent review looking to determine the true prevalence of hypertension in athletes.

    Article  CAS  PubMed  Google Scholar 

  28. Berge HM, Andersen TE, Solberg EE, Steine K. High ambulatory blood pressure in male professional football players. Br J Sports Med. 2013;47(8):521–5.

    Article  PubMed  Google Scholar 

  29. Shah SA, Chu BW, Lacey CS, et al. The impact of acute energy drink consumption on blood pressure parameters: a meta-analysis. Ann Pharmacother. 2016 Jun 23. pii: 1060028016656433. [Epub ahead of print]

  30. Wilens TE, Hammerness PG, Biederman J, et al. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2005;66(2):253–9.

    Article  PubMed  Google Scholar 

  31. Kozor R, Grieve SM, Buchholz S, et al. Regular cocaine use is associated with increased systolic blood pressure, aortic stiffness and left ventricular mass in young otherwise healthy individuals. PLoS One. 2014;9(4):e89710.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Riebe D, Fernahall B, Thompson PD. The blood pressure response to exercise in anabolic steroid users. Med Sci Sports Exerc. 1992;24(6):633–7.

    Article  CAS  PubMed  Google Scholar 

  33. Boldo A, White WB. Blood pressure effects of the oral contraceptive and postmenopausal hormone therapies. Endocrinol Metab Clin North Am. 2011;40(2):419–32.

    Article  CAS  PubMed  Google Scholar 

  34. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med. 1993;153(4):477–84.

    Article  CAS  PubMed  Google Scholar 

  35. Wolk R, Shamsuzzaman AS, Svatikova A, et al. Hemodynamic and autonomic effects of smokeless tobacco in healthy young men. J Am Coll Cardiol. 2005;45(6):910–4.

    Article  CAS  PubMed  Google Scholar 

  36. Huang SH, Johnson K, Pipe AL. The use of dietary supplements and medications by Canadian athletes at the Atlanta and Sydney Olympic Games. Clin J Sport Med. 2006;16:27–33.

    Article  PubMed  Google Scholar 

  37. Tricker R. Painkilling drugs in collegiate athletics. J Drug Educ. 2000;30:313–24.

    Article  CAS  PubMed  Google Scholar 

  38. Mahler N. Misuse of drugs in recreational sports. Ther Umsch. 2001;58(4):226–31.

    Article  CAS  PubMed  Google Scholar 

  39. Pellica A. Athlete’s heart and hypertrophic cardiomyopathy. Curr Cardiol Rep. 2000;2:166–71.

    Article  Google Scholar 

  40. Messerli FH, Ventura HO, Amodeo C. Osler’s maneuver and pseudohypertension. N Engl J Med. 1985;312(24):1548–51.

    Article  CAS  PubMed  Google Scholar 

  41. Hulsen HT, Nijdam ME, Bos WJ, et al. Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and low central pressure and its determinants. J Hypertens. 2006;24:1027–32.

    Article  CAS  PubMed  Google Scholar 

  42. McEniery CM, Yasmin, Wallace S, et al. Increased stroke volume and aortic stiffness contribute to isolated systolic hypertension in young adults. Hypertension. 2005;46:221–6.

    Article  CAS  PubMed  Google Scholar 

  43. Wilkinson IB, Franklin SS, Hall IR, et al. Pressure amplification explains why pulse pressure is unrelated to risk in young subjects. Hypertension. 2001;38:1461–6.

    Article  CAS  PubMed  Google Scholar 

  44. Mazic S, Suzic Lazic J, Dekleva M, et al. The impact of elevated blood pressure on exercise capacity in elite athletes. Int J Cardiol. 2015;180:171–7.

    Article  PubMed  Google Scholar 

  45. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507–20. Most recent recommendations for treating hypertension in adults.

    Article  CAS  PubMed  Google Scholar 

  46. Carre F, Handschuh R, Beillot J, et al. Effects of captopril chronic intake on the aerobic performance and muscle strength of normotensive trained subjects. Int J Sports Med. 1992;13(4):308–12.

    Article  CAS  PubMed  Google Scholar 

  47. D’Este D, Giada F, Sartori F, et al. The effects of enalapril on basal arterial pressure at rest and during exercise and on cardiac performance in hypertensive athletes. G Ital Cardiol. 1990;20(10):935–9.

    PubMed  Google Scholar 

  48. Palla M, Ando T, Androulakis, et al. Renin-angiotensin system inhibitors vs other antihypertensives in hypertensive blacks: a meta-analysis. J Clin Hypertens. 2016. doi:10.1111/jch.12867. [Epub ahead of print]

  49. Brown NJ, Ray WA, Snowden M, et al. Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema. Clin Pharmacol Ther. 1996;60:8–13.

    Article  CAS  PubMed  Google Scholar 

  50. Kaplan NM. The CARE study: a postmarketing evaluation of ramipril in 11,100 patients. Clin Ther. 1996;18:658–70.

    Article  CAS  PubMed  Google Scholar 

  51. Li EC, Heran BS, Wright JM. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension. Cochrane Database Syst Rev. 2014;22(8)

  52. Barrow MW, Clark KA. Heat-related illnesses. Am Fam Physician. 1998;58(3):749–56. 759.

    CAS  PubMed  Google Scholar 

  53. Beavers CJ, Dunn SP, Macaulay TE. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema. Ann Pharmacother. 2011;45(4):520–4.

    Article  CAS  PubMed  Google Scholar 

  54. Product Information: COZAAR(R) oral tablets, losartan potassium oral tablets. Merck & Co., Inc., Whitehouse Station, NJ, 2005.

  55. Materson BJ, Reda DJ, Cushman WC, et al. Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. N Engl J Med. 1993;328(13):914.

    Article  CAS  PubMed  Google Scholar 

  56. Sareli P, Radevski IV, Valtchanova ZP, et al. Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Arch Intern Med. 2001;161(7):965.

    Article  CAS  PubMed  Google Scholar 

  57. Heffernan KS, Jae SY, Wilund KR, et al. Racial differences in central blood pressure and vascular function in young men. Am J Physiol Heart Circ Physiol. 2008;295:H2380–7.

    Article  CAS  PubMed  Google Scholar 

  58. Pool PE, Seagren SC, Salel AF. Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double blind, placebo-controlled evaluation for systemic hypertension. Am J Cardiol. 1985;56(16):86II–91II.

    Article  Google Scholar 

  59. Agostini P, Doria E, Berti M, et al. Exercise performance in patients with uncomplicated essential hypertension. Effects of nifedipine-induced acute plod pressure reduction. Chest. 1992;101(6):1591–6.

    Article  Google Scholar 

  60. Howe AS, Boden BP. Heat-related illness in athletes. Am J Sports Med. 2007;35(8):1384–95.

    Article  PubMed  Google Scholar 

  61. WADA Publishes 2016 Prohibited List (September 29, 2015). World Anti-Doping Agency. 2015. Web. Accessed July 29, 2016. Very important reference to be familiar with if treating athletes with any condition.

  62. Mitchell JH, Haskell W, Snell P, Van Camp SP. Task Force 8: classification of sports. J Am Coll Cardiol. 2005;45(8):1367–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Care, University of Iowa Hospitals and Clinics, Iowa City, IA, USA

    Kevin T. Schleich

  2. Department of Family Medicine, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA

    Kevin T. Schleich & Michael E. Ernst

  3. Department of Orthopaedic Surgery & Sports Medicine, University of Kentucky, Lexington, KY, USA

    M. Kyle Smoot

  4. Department of Pharmacy Practice and Science, College of Pharmacy, The University of Iowa, Iowa City, IA, USA

    Michael E. Ernst

Authors
  1. Kevin T. Schleich
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Kyle Smoot
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael E. Ernst
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael E. Ernst.

Ethics declarations

Conflict of Interest

Drs. Schleich, Smoot, and Ernst declare no conflicts of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Antihypertensive Agents: Mechanisms of Drug Action

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schleich, K.T., Smoot, M.K. & Ernst, M.E. Hypertension in Athletes and Active Populations. Curr Hypertens Rep 18, 77 (2016). https://doi.org/10.1007/s11906-016-0685-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11906-016-0685-y

Keywords

Search

Navigation